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Abstract 
An enzyme-linked immunosorbent assay (ELISA) 
based on the svnthetic Deutide (NANP)m was used to 
characterize the sporo;oGe an&bodies ‘in an unusual 
Plasmodium falciparum outbreak in a non-malarious 
area in Sri Lanka. A positive antibody response was 
seen in 62% of patients with their first P. falciparum 
illness. There was no correlation between sporozoite 
antibodies and the antibody against blood stages, 
determined by immunofluorescence assay. The 
majority (91%) of the patients lost the antibodies to 
circumsporozoite (CS) protein within one year (in the 
absence of re-exposure). Three patients had high 
levels of CS antibodies even after one year, and this 
persistence was related to the level of the initial 
antibody response. In the area of the outbreak 10% of 
schoolchildren had antibodies to the (NANP)a pep- 
tide. 21% of the 42 children with present or past overt 
malaria were antibody positive. Of the children with 
no such background, 8% were antibody positive. The 
corresponding seropositivity rates for asexual blood 
stages were 31% and 1% for the 2 groups respectively. 
It is concluded that (NANP)@ ELISA is potentially a 
valuable tool in sero-epidemiology, particularly in 
situations of seasonal transmission and recurrences 
due to drug resistance. 
Introduction 
An antibody response to the sporozoite stages of 
malaria parasites were first described by VANDEN- 
BERG et al. (1969) using the circumsporozoite pre- 
cipitation test. However, it was only with the intro- 
duction of an immunofluorescence (IFA) test for the 
detection of antibodies to sporozoites that a human 
antibodv response to these stages of the Plasmodium 
falcipa&m parasite was docum&ted by NARDIN et al. 
(1979). There workers showed that in an area with 
hypeiendemic malaria, The Gambia, sporozoite anti- 
bodies were widely prevalent in humans, and that 
seropositivity increased with age. Similar observations 
were reported for human P. vivan infections in 
Thailand (TAFCHAISRI et al., 1983). However, due to 
the scarcity of antigen used for both these techniques, 
thev were of limited applicabilitv in epidemiological 
studies. The cloning bf the ci&umsporozoite TCS) 
orotein antigen of P. falcibarum and the elucidation of 
its structuri (DAME et ai., 1984; ENEA et al., 1984; 
NUSSENZWEI~~ & NUSSEN~WEIG,~~~~) paved the way 
for the use of recombinant (HOFFMAN et al.. 1986) 
and synthetic antigens (ZAV~LA er al., 1986;‘CAMP: 
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BELL et al., 1987; DEL GIUDICE et al., 1987a) in 
immunoassays. Studies on the immune responses to 
the CS vrotein antigen in P. falciparum have been 
carried out using &ese techniques, and have con- 
firmed the data obtained usine the IFA test. Howev- 
er, many questions remain & be answered. 
As most of the studies on the CS antibody response 
reported to date have been carried out in areas of 
hyper- or holoendemic malaria, there are limited data 
on the response to exposure to a single infection and 
the duratibn of the response. - 
An unusual outbreak of P. falciDarum malaria in a 
village in a normally non-ma&o& area of Sri Lanka 
offered us an opportunity to investigate some of these 
questions. The outbreak was associated with the 
recent completion of a dam upstream of the village 
and the formation of pools of water in the river bed 
during the severe drought experienced in 1987 
(WIJESUNDERA, 19881. The village had not extwi- 
kncid malaria before; and thus provided a ‘viigin’ 
oouulation with resoect o P. falciDarum. This conten- 
60; was further &ported *bv the fact that in the 
recent past (until l-984) ma&a in Sri Lanka has 
nredominantlv (95%) been due to P. vivax. This 
deport doc&e&s the antibody response of these 
villagers to the (NANP)w synthetic antigen (DEL 
GIUDICE et al., 1987b). 
Materials and Methods 
Venous blood samples from 101 patients with 
parasitologically confirmed P. falcipanrm malaria 
were obtained after informed consent. The patients 
were residents of a village (Waratenne, elevation 
500 m) in a hitherto non-malarious area of the island. 
This village, which had a population of 458 in 75 
households, was subjected to an outbreak of P. 
falciparum malaria during January-June 1987 (WI- 
JESUNDERA, 1988); there has been no significant 
malaria in this area before or since then. The patients 
studied were those who attended a voluntary treat- 
ment health centre during May-June 1987. During 
this period, of the 184 confirmed malaria patients 
treated at the clinic, 106 were from this village (an 
attack rate of 23%). Chloroquine or amodiaquine was 
used for treatment of the acute attack, but all the 
patients suffered one or more recrudescences of 
illness, in spite of therapy (evidence of RI resistance). 
At the time of blood collection, 90% of patients had 
received 2 or more, and 63% 3 or more, courses of 
drugs within a 2-3 month period. The outbreak was 
contained using sulfadoxinelpyrimethamine 
(Fansidar@). 
A second blood sample was collected one year later 
from 55 of these patients, together with information 
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of febrile episodes and travel to malarious areas 
during the intervening year. 
Sera from 234 apparently healthy schoolchildren in 
2 schools in this area were also collected in June the 
same year, after obtaining parental consent. 
Sera from 115 schoolchildren from an area where 
malaria was not active (Hatton; elevation 1270 m) 
were collected as controls. 
Detection of antibodies jo P. fa&iparum sporozoites by 
jENLAI~~~e-enzyme-ltnked tmmunosorbent assay 
The (NANP)40-ELISA was carried out as described 
previously (DEL GIUDICE et al., 1987a). ELISA plates 
were precoated with (NANP)m antigen (test antigen) 
or phosphate-buffered saline (control antigen) at the 
World Health Organization Immunology Research 
and Training Centre in Geneva, transported to Sri 
Lanka, and stored at 4°C until used within 12 weeks 
of coating. These precoated plates have been shown to 
be stable for at least 6 months at 4”C, 25°C (room 
temperature) and 37°C (Del Giudice, unpublished 
data). An anti-human imrnunoglobulin (Ig) G/M/A/ 
kappa/lambda conjugate (Dako, Denmark) was used 
at a dilution of 1 in 400, the optimal dilution as 
assessed by chess board titrations. The optical density 
(OD) was read on an ELISA reader (Dynatech 
Minireader) at 495 run. Serum specimens were 
screened at a dilution of 1 in 200 in duplicate wells, on 
plates with test antigen and control antigen respec- 
tively. The difference of OD between the test antigen 
and control antigen for a given serum was taken as the 
indicator of specific reaction and is the quantity used 
in all analysis of data below. A negative and a positive 
control serum were included in each day’s experi- 
ment .
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Detection of antibodies agaitlst asexual blood stages of P. 
falciparum by indirect fluorescent assay (ZFA) 
IFA was carried out according to standard methods 
using cultured P. falciparum. Thin f&n antigen slides 
air-dried and acetone-fixed (provided by Dr Allan 
Saul of the Queensland Institute of Medical Research, 
Australia) and fluorescein isothiocyanate-conjugated 
goat anti-human IgG (Nordic, Netherlands) at a 
working dilution of 1 in 50 in 0.05% Evans blue in 
PBS (pH 7.2) were used. 
Results 
Circumsporozoite antibody response in he control popula- 
tion 
The CS antibody results for the 115 control sera are 
shown in Fig. 1, C. The mean OD difference was 
O-027 (standard deviation (SD) = O-09). The cut-off 
value in the test was computed as 0.2 (mean + 2SD) 
for a 95% level of confidence and 0.3 (mean + 3 SD) 
for a 99% level of confidence. Five of these children 
(4%) were positive at an OD difference ~0.2, and 2 
(2%) were positive at an OD difference 2 0.3. 
Circumsporozoite antibody levels in schoolchildren in the 
area of the outbreak 
The CS antibody results for these children are 
shown in Fig. 1, B. Twenty-four of 234 (10%) of the 
children showed an OD difference 2 0.2 and 17 (7%) 
a difference L O-3. Fifteen of 234 (6%) sera tested by 
IFA for asexual stage antibodies were positive at a 
cut-off titre of l/32. Only 4 of the sera were positive 
by both tests. On the basis of clinical history (febrile 
episodes), palpable spleen, and blood fihn positivity 
(5 children), 42 children were classified as having, or 
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Fii. 1. The (NANF’)40 enzyme-linked immumsorbent assay results of (A) patients with acute malaria, (B) scbo~lchildrrn in the malaria outbreak 
area, and (C) schoolchildren in a non-tnalarious area. The teem plus 2 and 3 standard deviations of the control @‘oup (c) are shown. 
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group). Nine of 42 (21%) of them were positive for CS 
antibody, compared to 15 of 192 (8%) positive in the 
remaining children with no such history. In contrast, 
31% of the ‘malaria! group were IFA positive, while 
only 1% of those with no history of malaria were IFA 
positive (Table). 
Circumsporozoite antibody response of patients with acute 
faiciparum malaria 
The CS antibody response of the patients with 
acute malaria is shown in Fig. 1, A. Sixty-three of the 
Table. Circumsporozoite protein and indirect fluorescent 
antibody response of schoolchiidren in study area based 
on clinical diagnosis 
Children with 
Children with no history of 
recent malaria recent malaria 






so.2 177 (92;) 
IFATb 
Positive 13 (31%) 
Negative 
2 (1%) 
29 (69%) 190 (99%) 
a Response (difference in optical density) to (NANP).+, 
enzyme-linked immunosorbent assay. 
b Response to indirect fluorescent antibody test using 
blood-stage antigen. 
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Fig. 2. The (NANP)a enzyme-linked immunosorhent assay results 
of the acute (A) and ooe year follow-up (B) sera of 55 patients with 
falciparum malaria. The mean plus 2 and 3 standard deviations of the 
control group (C in Fig. 1) are shown. 
101 (62%) showed an OD difference 2 0.2, and 59 
(57%) showed an OD difference > 0.3. The remain- 
der did not appear to have mounted an antibody 
response to the (NANP)a antigen. 
The antibody OD difference values for the 55 
patients retested one year after their initial infection, 
together with the data on the respective ‘acute’ sera, 
are shown in Fig. 2; all but 5 of them (91%) had lost 
the CS antibody. These 5 patients gave no history of 
malaria, febrile episodes or travel to malarious areas 
during the intervening year. Three of these patients 
appeared to retain high levels of CS antibody (OD 
difference > O-3). 
Optical density difference and number of recrudescences 
The CS antibody OD difference values were similar 
in those patients experiencing 2,3, or more recrudesc- 
ences. The values obtained were: patients with 2 or 
fewer recrudescences (n = 17), mean = O-41, 
SD = 0.43; 3 recrudeyences (n = 21), 
m e a n 
SD = 0.37; 4 or mar< recrudescence: (n 2 32)’ 
mean = O-41, SD = 0.79. The median values for th; 
three groups were 0.28, 0.26 and 0.2 respectively. 
Indirect fluorescence assay response to asexual stage 
antigens of P. falciparum 
Of the 101 sera tested for antibodies against asexual 
stages, 92 (91OYk) were positive at a screening dilution 
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Fig. 3. The relationship between (NANP), enzyme-linked immuno- 
sorbcnt assay results and the indirect fluorescent asexual stage 
antibody response in 75 patients with acute falciparum malaria. 
strain. A high percentage (8%) of schoolchildren in 
the area of the outbreak; with no evidence suggestive 
of clinical malaria. were nositive for CS antibodies. 
while only 1% were pos’itive for blood-stage anti- 
bodies. In view of the fact that they had not taken 
chemoprophylaxis, this could be used as an estimate 
of exposure to infective bites in the absence of clinical 
disease. Of the children from the non-malarious area, 
2-4% had antibodies to (NANP)w. Although their 
history suggested that they had never been exposed to 
malaria, in a tropical country it is not possible 
completely to rule out contact with the parasite. 
However, the possibility that some positive results 
with the CS ELISA may have been false positives, or 
may have been due to cross-reacting antibbdies, needs 
to be considered. Overall. the results of the studv 
confirm the earlier observations that the antisporozd- 
ite antibodies are of short duration, unrelated to 
recrudescence, and independent of the anti-blood- 
stage antibodies. The (NANP)w ELISA shows prom- 
ise of being a potentially valuable sero-epidemiologic- 
al tool in situations with seasonal transmission, where 
trends are more important than individual infections. 
Furthermore, it is useful in situations of low drug 
resistance and repeated recrudescences, where the 
antibody response against blood-stages is of limited 
value in sero-epidemiology. 
38 
of 1 in 32. With the 75 specimens in which adequate 
serum was available. the IFA antibodv was titrated at 
dilutions of 1 in 32, 1 in 128, and i in 512. There 
appeared to be no correlation of the IFA titres with 
the corresponding CS OD differences (Fig. 3). 
Discussion 
The ELISA for CS antibodies using the synthetic 
peptide (NANP)m antigen has been earlier shown to 
give results comparable to that using whole sporozo- 
ites (DEL GIUDICE et al.. 1987b). The nresent studv 
reports the CS antibody ~espo& in a f&t exposure to 
falciparum malaria; the only published report of 
comparable data was that by DEL GIUDICE et al. 
(1987b) on Caucasians returning from Africa with 
acute P. falciparum malaria. - 
In the nresent studv. 4962% of the individuals had 
detectabk levels of &ti (NANP)a antibodies after 
their initial exposure to P. fukiparum. These results 
are comparable to the 48% antibody prevalence in 51 
Caucasian travellers with falciparum malaria reported 
by DEL GIUDICE et al. (1987b). Both studies indicated 
that an antibody response to the NANP epitope of the 
CS antigen is not universal, following a single malarial 
infection. WEBSTER et al. (1987) reported that CS 
antibody titres (to the R32tet32 recombinant antigen) 
declined rapidly after the onset of illness, with an 
apparent half-life for antibody of 27 d. The ELISA 
OD at day 67 appeared to be related to the peak OD 
value obtained during the acute illness. In the present 
study! 3 sera of the 55 patients retested after one year 
had significantly high OD difference values (Fig. 2). 
These patients did not give a history of malaria or 
travel to malarious areas in the intervening year. 
These sera were among those that gave maximal initial 
(acute serum) ELISA positivity, which agrees with 
the observation by WEBSTER et al. (1987). DRUILHE et 
al. (1986), using the IFA, also showed that antisporo- 
zoite antibodies could persist in the absence of 
re-exposure. In the present study, most patients had 
reneated recrudescences of malaria. The clinical and 
ep>demiological evidence points to these being re- 
crudescences rather than reinfections. There was 
clinical evidence of partial chloroquine/amodiaquine 
resistance of the enidemic strain. Of 77 patients 
treated with a standard drug regimen of amodiaquine 
0400 me base over 72 h). 62 (81%) had recrudescent 
ilhress~&hin 28 d; noneof 71 patients treated with 
sulfadoxine/pyrimethamine (Fansida@) had a further 
recrudescence. WEBSTER et al. (1987) suggested that 
the CS antibody response was unaffected by re- 
crudescences of malaria, but showed a boost following 
reinfection. In the present study, the OD difference 
values of patients who had 2, 3, or more recrudesc- 
ences of illness did not show a significant difference, 
supporting the contention of WEBSTER et al. (1987) 
that recrudescences do not effect the CS antibody 
titre. 
Of the 234 schoolchildren examined from the area, 
42 (18%) were assessed to have had clinical malaria. In 
this group the IFA, as expected, gave a higher 
wsitivitv rate (31%) than did the CS ELISA (21%). 
The correspondence between the tests was poor: Four 
of the children (one showed only gametocytaemia), 
although asymptomatic at examination, showed per- 
sistence of asexual parasitaemia, evidence supportive 
of the partial drug resistance of the infecting parasite 
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